��������

Dominic J. Clementi is an experienced finance professional currently serving as Finance Controlling Manager at Kedrion Biopharma since May 2022. Previously, Dominic held the positions of Senior Financial Analyst GTN at LEO Pharma from April 2018 to May 2022, and FP&A Manager at Pfizer Inc. from July 2015 to January 2018. Earlier roles include Senior Accountant at Avaya Inc. from July 2013 to June 2015, Customer Credit Management at Johnson & Johnson from June 2012 to May 2013, and Expense Analyst at State Street Corporation (following the acquisition of Merrill Lynch mutual funds) from January 2004 to August 2011. Dominic holds a degree from Rowan University.